Homepage Patients Professionals Contact About Us Press  

chairman's message

Imperial College London Diabetes Centre (ICLDC) was one of the first facilities to be established as part of Mubadala Healthcare’s vision to create a world-class healthcare network in Abu Dhabi. The Centre is a prime example of how this vision is being realized - addressing one of the most pressing healthcare issues in the region by harnessing the world-renowned medical expertise of Imperial College London and creating a centre of excellence for Abu Dhabi.

Since it opened in 2006, ICLDC has treated over 20,000 patients and reached out to countless others through its cutting-edge research, awareness campaigns, and community outreach programs. By raising knowledge and awareness about the condition and through ongoing research, ICLDC is paving the way both to improve the quality of life for those living with diabetes and ultimately to reduce its prevalence in the region.


In its first three years of operation ICLDC has helped to improve the lives of thousands of patients in the UAE. We are immensely proud of the Centre and its excellent work and look forward to seeing its operations and subsequent impact increase in the years to come.

Suhail Mahmood Al Ansari

Chairman of Imperial College London Diabetes Centre and Executive Director of Mubadala Healthcare

chairman's message


|
|
|
|
Copyright © 2005-2007 Imperial College London Diabetes Centre


DISCLAIMER:
The information and resources on this web site (1) are not intended to represent the opinions of Imperial College of London Diabetes Centre, its licensors, service providers, affiliates or employees; (2) do not constitute medical advice, diagnosis and treatment; and (3) are not intended to be a substitute for professional medical advice or for the care that patients receive from their physicians.  Never disregard professional medical advice or delay in seeking it because of something you have read on the Imperial College of London Diabetes Centre website!  Your use of this site is subject to its Terms of Use (hyperlinked).